SECURE Post-Market Study (SECURE PMS)
SECURE Post-Market Study (PMS): Atraumatic Sutureless Nerve Repair - Evaluation of COAPTIUM CONNECT in a REal-World Clinical Setting
The purpose of this post-market study is to generate post-market, real- world evidence on the safety and performance of COAPTIUM® CONNECT with TISSIUM® LIGHT for the atraumatic sutureless repair of acute digital (sensory) injuries of the hand in adults through prospective data collection, to confirm safety and performance of the device.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Raicca Haqqi
- 电话号码:617-875-5120
- 邮箱:rhaqqi@tissium.com
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Subjects aged 18 years or older at the time of signing the informed consent form.
-
Subjects undergoing surgical repair of an acute peripheral nerve injury as follows:
- Digital sensory nerve with associated tendon injury, OR
- Digital sensory nerve without tendon injury.
-
Nerve must be completely transected and appropriate for primary repair.
-
Nerve ends can be reapproximated without excessive tension and without the need for nerve grafting.
-
Wound can be adequately cleaned and has sufficient healthy soft tissue to allow primary closure without adjunctive soft tissue procedures.
-
Nerve injury is deemed by the surgeon to be suitable for repair using COAPTIUM® CONNECT.
-
Subject is willing and able to provide written informed consent prior to any study specific procedures.
-
Subject is willing and able to complete all required visits and procedures at baseline, 1 month, 3 months, 6 months, and 12 months.
Exclusion Criteria:
-
Known or suspected hypersensitivity to any constituents of the product, including the polymer (Aminated polyglycerol sebacate acrylate) or the additive FD&C Blue No. 1 Dye (brilliant blue FCF);
-
Known diagnosis of peripheral neuropathy;
-
Any injury requiring revascularization due to critical ischemia from damage to the blood vessels;
-
Subject's traumatic lesion is older than 14 days at the time of surgery;
-
Use of photosensitizing medications at the time of informed consent.
-
Concomitant neuromodulator medication;
-
Life expectancy less than 1 year;
-
History of neuropathic pain in the affected extremity;
-
History of injury to the nerve being studied;
-
Missing contralateral digit or history of injury to the contralateral digit (comparison/control area);
-
Unwillingness/inability to follow postoperative instructions/follow-up visits;
-
Concomitant intake of systemic immunosuppressive medications, steroids (>20mg of prednisone /day or equivalent) and chemotherapy;
-
Prior radiation therapy to the surgical site;
-
Pregnancy detected by a positive pregnancy test or planned pregnancy during the study period or breast-feeding women;
-
History of chronic ischemic disease involving the affected limb;
-
Diagnosis of type 1 diabetes mellitus or uncontrolled Type 2 diabetes mellitus (at the discretion of the investigator);
-
Subject is currently participating in a study involving an investigational device/drug that has not reached its primary endpoints or would interfere with the study endpoints.
Note: Trials requiring extended follow-up for products that were investigational, but have since become commercially available, are not considered investigational trials;
-
Previous injury, surgery, pathology involving the same nerve or extremity;
-
Active infection at the surgical site;
-
In the opinion of the Investigator, the subject is not a suitable candidate for the clinical investigation.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:COAPTIUM® CONNECT
Nerve Coaptation Device |
COAPTIUM® CONNECT with TISSIUM® LIGHT is indicated for the sutureless repair of peripheral nerve injuries not in continuity in which a gap closure ≤ 1 cm is present or can be achieved with flexion of the extremity.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Sensory Recovery at 6-Months
大体时间:6-Months
|
Rate of higher threshold meaningful recovery (HTMR) at 6 months post-surgery |
6-Months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Sensory Recovery at 12-Months
大体时间:12-Months
|
Rate of higher threshold meaningful recovery (HTMR) at 12 months post-surgery |
12-Months
|
合作者和调查者
赞助
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- PF00004-CLPR-003
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.